| Previous close | 9.77 |
| Open | 9.77 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 185.00 |
| Expiry date | 2025-12-19 |
| Day's range | 9.77 - 9.77 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
PR NewswireAbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week®
AbbVie (NYSE: ABBV) announced it is presenting 15 abstracts at the 2024 Digestive Disease Week (DDW) Annual Meeting, being held May 18-21 in Washington, D.C., and virtually.
ZacksAre You Looking for a High-Growth Dividend Stock?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
ZacksAbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal
AbbVie (ABBV) inks an option-to-license and collaboration deal with Gilgamesh to develop next-generation therapies for psychiatric disorders.
© 2024 Yahoo. All rights reserved.